Home Cart Sign in  
Chemical Structure| 383432-38-0 Chemical Structure| 383432-38-0

Structure of CP-724714
CAS No.: 383432-38-0

Chemical Structure| 383432-38-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CP-724714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM, > 640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met etc.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CP-724714

CAS No. :383432-38-0
Formula : C27H27N5O3
M.W : 469.54
SMILES Code : O=C(NC/C=C/C1=CC2=C(NC3=CC=C(OC4=CC=C(C)N=C4)C(C)=C3)N=CN=C2C=C1)COC
MDL No. :MFCD11983048
InChI Key :LLVZBTWPGQVVLW-SNAWJCMRSA-N
Pubchem ID :9874913

Safety of CP-724714

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of CP-724714

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCC1954 0.1 µM and 1 µM To test the inhibitory effect of CP-724714 on the proliferation of HCC1954 cells. Results showed that CP-724714 alone had limited effect on cell proliferation, but when combined with the PI3K inhibitor LY294002, it significantly inhibited cell proliferation. Int J Oncol. 2017 Oct;51(4):1320-1330
MCF10A/HER2/PIK3CA-H1047R 0.1 µM and 1 µM 9 days To test the inhibitory effect of CP-724714 on the proliferation of MCF10A/HER2/PIK3CA-H1047R cells. Results showed that CP-724714 alone had little to no effect on cell proliferation, but when combined with the PI3K inhibitor LY294002, it significantly inhibited cell proliferation. Int J Oncol. 2017 Oct;51(4):1320-1330
ST cells 80 μM Evaluate the toxicity of CP-724714 on ST cells, showing no significant toxicity at concentrations below 80 μmol/L Virol Sin. 2023 Oct;38(5):778-786
IPI-2I cells 40 μM 24 h Evaluate the toxicity of CP-724714 on IPI-2I cells, showing no significant toxicity at concentrations below 40 μmol/L Virol Sin. 2023 Oct;38(5):778-786
Vero cells 40 μM 24 h Evaluate the toxicity of CP-724714 on Vero cells, showing no significant toxicity at concentrations below 40 μmol/L Virol Sin. 2023 Oct;38(5):778-786
human neutrophils 10 μM 6 h accelerated neutrophil apoptosis Elife. 2019 Oct 15;8:e50990
HaCaT cells 5 µM 1 h To investigate the effect of CP-724714 on Akt and ERK phosphorylation. Results showed that 5 µM CP-724714 significantly reduced phosphorylation levels of Akt and ERK. Front Immunol. 2024 Feb 2;15:1335302.
HaCaT cells 2.5 µM 1 h To investigate the inhibitory effect of CP-724714 on ErbB2 phosphorylation. Results showed that 2.5 µM CP-724714 significantly inhibited phosphorylation of ErbB2 at Y877 site. Front Immunol. 2024 Feb 2;15:1335302.
HaCaT cells 5 µM 1 h To investigate the inhibitory effect of CP-724714 on ErbB2 phosphorylation. Results showed that 5 µM CP-724714 significantly inhibited phosphorylation of ErbB2 at Y1221/1222 sites. Front Immunol. 2024 Feb 2;15:1335302.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Zebrafish Tail fin injury inflammation model Immersion 10 μM 16-hour pretreatment before injury Reduced neutrophil number at the injury site Elife. 2019 Oct 15;8:e50990

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.65mL

2.13mL

1.06mL

21.30mL

4.26mL

2.13mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories